Physico-chemical characteristics of uranium compounds: A review

References

• André S, Métivier H, Auget D, Lantenois G, Boyer M, Masse R. 1989. Assessment of uranium tetrafluoride dissolution in the lung by in vivo and in vitro methods. Radiat Protect Dosim 26:75–81.
   Google Scholar
• Ansoborlo E, Stather J. 2000. Review of the caractherisation of hot particles released into the environment and path ways for intake of particles. Radiat Protect Dosim 92:139–143.
   Google Scholar
• *Ansoborlo E, Gibert B, Chalabreysse J. 1990a. Influence des propiétés physico-chimiques du tétrafluorure d'uranium sur les modalités de la surveillance de l'exposition chronique à ce composé [Influence of physico-chemical properties of uranium tetrafluoride on monitoring of chronic exposure to this compound]. Radioprotection 25:225–234.
   Google Scholar
• Ansoborlo E, Chalabreysse J, Escallon S, Hengé-Napoli MH. 1990b. In vitro solubility of uranium tetrafluoride with oxidizing medium compared with in vivo solubility in rats. Int J Radiat Biol 58:681–689.
   PubMed Web of Science ®Google Scholar
• *Ansoborlo E, Chalabreysse J, Hengé-Napoli MH, Pujol E. 1992. In vitro chemical and cellular tests applied to uranium trioxide with different hydration states. Environ Health Perspect 97:139–143.
   PubMed Web of Science ®Google Scholar
• *Ansoborlo E, Hengé-Napoli MH, Donnadieu-Claraz M, Roy M, Pihet P. 1994. Industrial exposure to uranium aerosols at laser enrichment processing facilities. Radiat Protect Dosim 53:163–167.
   Google Scholar
• *Ansoborlo E, Claraz M, Hengé-Napoli MH, Métivier H, Garden J, Cheynet MC. 1995a. Etude de l'exposition industrielle à des aérosols d'uranium dans le procédé d'enrichissement par laser. Méthodes et résultats [Study of industrial exposure to uranium aerosols in the laser enrichment process. Methods and results]. Radioprotection 30:13–24.
   Google Scholar
• Ansoborlo E, Hengé-Napoli MH, Rannou A, Pihet P, Dewez P. 1995b. French experience in the field of internal dosimetry assessment at a nuclear workplace: Methods and results on industrial uranium dioxide. J Radioanalyt Nuclear Chem 197:161–172.
   Google Scholar
• *Ansoborlo E, Hengé-Napoli MH, Roy M, Pihet P, Rannou A. 1995c. Implementation of the new ICRP respiratory tract model: Example of a potential exposure to an industrial oxide UO2. Bull Radiat Protect 18:1–7.
   Google Scholar
• *Ansoborlo E, Boulaud D, LeGuen B. 1997a. Distribution granulométrique d'aérosol d'uranium dans l'industrie française de fabrication du combustible [Size distribution of uranium aerosols in the French industry of fuel preparation]. Radioprotection 32: 319–330.
   Google Scholar
• *Ansoborlo E, Chazel V, Houpert P, Hengé-Napoli MH, Paquet F. 1997b. Interprétation des données physico-chimiques et biocinétiques pour le calcul de dose: Exemple d'un composé industriel UO2appauvri fabriqué pour le combustible MOX [Interpretation of physico-chemical and biokinetic data for dose calculation: example of an industrial compound of depleted UO2 used for MOX fuel preparation]. Radioprotection 32:603–615.
   Google Scholar
• *Ansoborlo E, Hodgson A, Stradling GN, Hodgson S, Métivier H, Hengé-Napoli MH, Jarvis NS, Birchall A. 1998a. Exposure implications for uranium aerosols formed at a new laser enrichment facility: Application of the ICRP respiratory tract and systemic model. Radiat Protect Dosim 79:23–27.
   Web of Science ®Google Scholar
• *Ansoborlo E, Guilmette RA, Hoover MD, Chazel V, Houpert P, Hengé-Napoli MH. 1998b. Application of in vitro dissolution tests to different uranium compounds and comparison with in vivo data. Radiat Protect Dosim 79:33–37.
   Web of Science ®Google Scholar
• *Ansoborlo E, Chazel V, Houpert P, Hengé-Napoli MH, Paquet F, Hodgson A, Stradling N. 1998c. Assessment of physico-chemical and biokinetic properties of uranium peroxide hydrate UO4. Health Phys 75:389–397.
   PubMed Web of Science ®Google Scholar
• Ansoborlo E, Chazel V, Hengé-Napoli MH, Pihet P, Rannou A, Bailey MR, Stradling N. 2002. Determination of the physical and chemical properties biokinetics and dose coefficients of uranium compounds handled during nuclear fuel fabrication in France. Health Phys 82:279–289.
   PubMed Web of Science ®Google Scholar
• *Bailey MR, Davis K. 2002. Estimations of kidney uranium concentrations from published reports of uranium intakes in man where subsequent effects on kidney function were monitored. London: The Royal Society.
   Google Scholar
• Bailey MR, Kreyling WG, André S, Batchelor A, Collier C, Drosselmeyer E, Ferron GA, Foster PP, Haider B, Hodgson A, et al. 1989. An interspecies comparison of the lung clearance of inhaled monodisperse cobalt oxide particles – Part I: Objectives and summary of the results. J Aerosol Sci 20:169–188.
   Web of Science ®Google Scholar
• Bailey MR, Ansoborlo E, Chazel V, Fritsch P, Hodgson A, Kreyling WG, Le Gall B, Newton D, Paquet F, Stradling N, et al. 2004. Radionuclide biokinetics database (RBDATA-EULEP): An update. Radiat Protect Dosim 112:535–536.
   PubMedGoogle Scholar
• Bailey MR, Ansoborlo E, Guilmette RA, Paquet F. 2007. Updating the ICRP human respiratory tract model. Radiat Protect Dosim 127: 31–34.
   PubMed Web of Science ®Google Scholar
• Ballou JE, Gies RA, Case AC, Haggard DL, Buschbom RL, Ryan JL. 1986. Deposition and early disposition of inhaled 233UO2(NO3)2and 232UO2(NO3)2 in the rat. Health Phys 51(6):755–771.
   PubMedGoogle Scholar
• Barrett PH, Bell BM, Cobelli C, Golde H, Schumitzky A, Vicini P, Foster DM. 1998. SAAM II: Simulation, analysis, and modeling software for tracer and pharmacokinetic studies. Metabolism 47:484–492.
   PubMed Web of Science ®Google Scholar
• *Beau PG, Chalabreysse J. 1989. Knowledge gained from bioassay data on some metabolic and toxicological features of uranium hexafluoride and its degradation products. Radiat Protect Dosim 26:107–112.
   Google Scholar
• Beckova V, Malatova I. 2008. Dissolution behaviour of 238U, 234U and 230Th deposited on filters from personal dosemeters. Radiat Protect Dosim 129:469–472.
   PubMedGoogle Scholar
• Bertelli L, Puerta A, Wrenn ME, Lipsztein JL, Moody JC, Stradling GN, Hodgson A, Fell TP. 1998. Specific absorption parameters for uranium octoxide and dioxide: Comparison of values derived from human data and those predicted from animal studies. Radiat Protect Dosim 79:87–90.
   Google Scholar
• Bigu J, DuPort P. 1992. Characterization of long-lived radioactive dust in uranium mill operations. Am Ind Hyg Assoc J 53:588–595.
   PubMed Web of Science ®Google Scholar
• Birchall A, Bailey MR, James AC. 1991. LUDEP. A lung dose evaluation program. Radiat Protect Dosim 38:167–174.
   Web of Science ®Google Scholar
• Birchall A, Puncher M, Marsh JW, Davis K, Bailey MR, Jarvis NS, Peach AD, Dorrian MD, James AC. 2007. IMBA Professional Plus: A flexible approach to internal dosimetry. Radiat Protect Dosim 125:194–197.
   PubMed Web of Science ®Google Scholar
• Chazel V, Houpert P, Ansoborlo E. 1998. Effect of U3O8 specific surface area on in vitro dissolution, biokinetics and dose coefficients. Radiat Protect Dosim 79:39–42.
   Web of Science ®Google Scholar
• Chazel V, Houpert P, Ansoborlo E, Hengé-Napoli MH, Paquet F. 2000a. Variation of solubility, biokinetics and dose coefficient of industrial uranium oxides according to specific surface area. Radiat Protect Dosim 88:223–231.
   Web of Science ®Google Scholar
• *Chazel V, Houpert P, Paquet F, Ansoborlo E, Hengé-Napoli MH. 2000b. Experimental determination of the solubility of industrial UF4 particulates. Radiat Protect Dosim 92:289–294.
   Web of Science ®Google Scholar
• *Chazel V, Houpert P, Paquet F, Ansoborlo E. 2001. Effect of absorption parameters on calculation of the dose coefficient: Example of classification of industrial uranium compounds. Radiat Protect Dosim 94:261–268.
   PubMed Web of Science ®Google Scholar
• *Chazel V, Gerasimo P, Dabouis V, Laroche P, Paquet F. 2003. Characterisation and dissolution of depleted uranium aerosols produced during impacts of kinetic energy penetrators against a tank. Radiat Protect Dosim 105:163–166.
   PubMed Web of Science ®Google Scholar
• *Chen J, Lariviere D, Timmins R, Verdecchia K. 2011. Estimation of uranium GI absorption fractions for children and adults. Radiat Protect Dosim 144:379–383.
   PubMedGoogle Scholar
• Cooper JR, Stradling GN, Smith H, Ham SE. 1982. The behaviour of uranium-233 oxide and uranyl-233 nitrate in rats. Int J Radiat Biol Relat Stud Phys Chem Med 41:421–433.
   PubMed Web of Science ®Google Scholar
• *Dang HS, Pullat VR, Pillai KC. 1992. Gastrointestinal absorption factor for uranium incorporated in diet. Radiat Protect Dosim 40:195–197.
   Google Scholar
• Davesne E, Paquet F, Ansoborlo E, Blanchardon E. 2010. Absorption of plutonium compounds in the respiratory tract. J Radiolog Protect 30:5–21.
   PubMedGoogle Scholar
• Dennis NA, Blauer HM, Kent JE. 1982. Dissolution fractions and half-times of single source yellowcake in simulated lung fluids. Health Phys 42:469–477.
   PubMed Web of Science ®Google Scholar
• Dorrian MD, Bailey MR. 1995. Particle size distributions of radioactive aerosols measured in workplaces. Radiat Protect Dosim 60:119–133.
   Web of Science ®Google Scholar
• Duport P. 1994. Radiation protection in uranium mining: Two challenges. Radiat Protect Dosim 53:13–19.
   Google Scholar
• Duport P, Robertson R, Ho K, Horvath F. 1991.Flow-through dissolution of uranium-thorium ore dust, uranium concentrate, uranium dioxide, and thorium alloy in simulated lung fluid. Radiat Protect Dosim 38:121–133.
   Google Scholar
• *Eidson AF, Griffith WC. 1984. Techniques for yellowcake dissolution studies in vitro and their use in biossay interpretation. Health Phys 46:151–163.
   PubMed Web of Science ®Google Scholar
• Eidson AF, Mewhinney JA. 1980. In vitro solubility of yellowcake samples from four uranium mills and the implications for bioassay interpretation. Health Phys 39:893–902.
   PubMed Web of Science ®Google Scholar
• *Eidson AF, Mewhinney JA. 1983. In vitro dissolution of respirable aerosols of industrial uranium and plutonium mixed-oxide nuclear fuels. Health Phys 45:1023–1037.
   PubMed Web of Science ®Google Scholar
• *Eidson AF, Griffith WC, Hahn FF, Pickrell JA. 1989. A model for scaling the results of U excretion rate studies in Beagle dogs to man. Health Phys 57:199–210.
   PubMedGoogle Scholar
• Ellender M. 1987. The clearance of uranium after deposition of the nitrate and bicarbonate in different regions of the rat lung. Human Toxicol 6:479–482.
   PubMedGoogle Scholar
• Etherington G, Cossonnet C, Franck D, Génicot JL, Hurtgen C, Jourdain JR, Le Guen B, Rahola T, Sovijärvi J, Stradling GN, et al. 2004. Optimisation of Monitoring for Internal Exposure (OMINEX), Report NRPB–W60 W60.
   Google Scholar
• *Fisher DR, Briant JK. 1994. Assessment of accidental intakes of uranyl acetylacetonate (UAA). Radiat Protect Dosim 53:263–267.
   Google Scholar
• Galibin GP, Parfenov YD. 1971. Inhalation study on metabolism of insoluble uranium compounds. In: Walton WH, editor. Inhaled particles III. Old Woking, Surrey: Unwin Brothers. pp. 201–208.
   Google Scholar
• *Glissmeyer JA, Mishima J, Gilchrist RL. 1979. Characterization of airborne uranium from test firings of XM774ammunition. Report PNL–2944.
   Google Scholar
• Guilmette RA, Cheng YS. 2009. Physicochemical characterization of Capstone depleted uranium aerosols IV: In vitro solubility analysis. Health Phys 96:292–305.
   PubMedGoogle Scholar
• *Harduin JC, Royer P, Piechowski J. 1994. Uptake and urinary excretion of uranium after oral administration in man. Radiat Protect Dosim 53:245–248.
   Google Scholar
• Harris WB. 1961. Experimental clearance of uranium dust from the human body. In: Davies CN, editor. Inhaled particles and vapours. Oxford, New York: Pergamon Press, pp. 209–220.
   Google Scholar
• Harrison JD. 1991. The gastrointestinal absorption of the actinide elements. Sci Total Environ 100:43–60.
   PubMed Web of Science ®Google Scholar
• Hengé-Napoli MH, Rongier E, Ansoborlo E, Chalabreysse J. 1989. Comparison of the in vitro and in vivo dissolution rates of two diuranates and research on an early urinary indicator of renal failure in humans and animals poisoned with uranium. Health Phys 26:113–117.
   Google Scholar
• Hodgson A, Moody JC, Stradling GN, Bailey C, Birchall A. 2000. Application of the ICRP Human Respiratory Tract model to uranium compounds produced during the manufacture of nuclear fuel. Report NRPB–M1156.
   Google Scholar
• Hodgson SA, Scott JE, Pellow PG, Hodgson A, Chazel V, Kreyling WG, Stradling GN. 2007. Biokinetics of uranium oxide particles with different sizes and specific surface areas. Report RPD-DAR-01-2007.
   Google Scholar
• Houpert P, Chazel V, Paquet F, Hengé-Napoli MH, Ansoborlo E. 1999. The effects of the initial lung deposit on uranium biokinetics after administration as UF4and UO4. Int J Radiat Biol 75: 373–377.
   PubMed Web of Science ®Google Scholar
• International Commission on Radiological Protection (ICRP). 1994. Human respiratory tract model for radiological protection. ICRP Publication 66. Annals of the ICRP. Oxford: Elsevier Science Ltd.
   Google Scholar
• ICRP. 1995a. Age-dependent doses to member of the public from intake of radionuclides: Part 3. Ingestion dose coefficients. ICRP Publication 69. Annals of the ICRP. Oxford: Elsevier Science Ltd.
   Google Scholar
• ICRP. 1995b. Age-dependent doses to members of the public from intake of radionuclides: Part 4. Inhalation dose coefficients. ICRP Publication 71. Annals of the ICRP. Oxford: Elsevier Science Ltd.
   Google Scholar
• ICRP. 1997. Individual monitoring for internal exposure of workers. ICRP Publication 78. Annals of the ICRP. Oxford: Elsevier Science Ltd.
   Google Scholar
• ICRP. 2002. Guide for practical application of the ICRP Human Respiratory Tract Model. Supporting guidance 3. Annals of the ICRP. Oxford: Elsevier Science Ltd.
   Google Scholar
• ICRP. 2006. Human alimentary tract model for radiological protection. ICRP Publication 100. Annals of the ICRP. Oxford: Elsevier Ltd.
   Google Scholar
• ICRP. 2014a. Occupational Intakes of Radionuclides, Part 1. Annals of the ICRP. Accepted for publication.
   Google Scholar
• ICRP. 2014b. Occupational Intakes of Radionuclides, Part 3. Annals of the ICRP. Accepted for publication.
   Google Scholar
• Kalkwarf DR. 1983. Dissolution rates of uranium compounds in simulated lung fluid. Sci Total Environ 28:405–414.
   PubMedGoogle Scholar
• *Karpas Z, Lorber A, Elish E, Kol R, Roiz Y, Marko R, Katorza E, Halicz L, Riondato J, Vanhaecke F, et al. 1998. Uptake of ingested uranium after low ‘acute intake’. Health Phys 74:337–345.
   PubMedGoogle Scholar
• *Kelso SM, Wraight JC. 1996. The measurement of aerosol size distributions (AMAD) in buildings on BNFL's Sellafield site. Radiat Protect Dosim 63:127–131.
   Google Scholar
• *Kravchik T, Oved S, Paztal-Levy O, Pelled O, Gonen R, German U, Tshuva A. 2008. Determination of the solubility and size distribution of radioactive aerosols in the uranium processing plant at NRCN. Radiat Protect Dosim 131:418–424.
   PubMedGoogle Scholar
• Kreyling WG, André S, Collier CG, Ferron GA, Métivier H, Schumann G. 1991. Interspecies comparison of lung clearance after inhalation of monodisperse solid cobalt oxide aerosol particles. J Aerosol Sci 22:509–535.
   Web of Science ®Google Scholar
• *La Touche YD, Willis DL, Dawydiak OI. 1987. Absorption and biokinetics of U in rats following an oral administration of uranyl nitrate solution. Health Phys 53:147–162.
   PubMed Web of Science ®Google Scholar
• Leggett RW, Harrison JD. 1995. Fractional absorption of ingested uranium in humans. Health Phys 68:484–498.
   PubMed Web of Science ®Google Scholar
• Leggett RW, Pellmar TC. 2003. The biokinetics of uranium migrating from embedded DU fragments. J Environ Radioact 64:205–225.
   PubMed Web of Science ®Google Scholar
• Leggett RW, Eckerman KF, Boice JD Jr. 2005. A respiratory model for uranium aluminide based on occupational data. J Radiol Prot 25:405–416.
   PubMed Web of Science ®Google Scholar
• *Marsh JW, Blanchardon E, Gregoratto D, Hofmann W, Karcher K, Nosske D, Tomasek L. 2012. Dosimetric calculations for uranium miners for epidemiological studies. Radiat Protect Dosim 149: 371–383.
   PubMed Web of Science ®Google Scholar
• Marshall M. 1976. Air sampling in laboratories and workplaces at AERE, Harwell. Ann Occup Hyg 19:153–157.
   PubMedGoogle Scholar
• Métivier H, Guillaumont R. 2007. Mieux connaître le devenir biologique des futurs matériaux nucléaires, une nécessité pour maintenir un bon niveau de radioproctection [To better know the biological behaviour of future nuclear materials: A need to maintain a good level of protection against ionising radiation]. Radioprotection 43:315–335.
   Google Scholar
• Métivier H, Poncy JL, Rateau G, Stradling GN, Moody JC, Gray SA. 1992. Uranium behaviour in the baboon after the deposition of a ceramic form of uranium dioxide and uranium octoxide in the lungs: Implications for human exposure. Radioprotection 27:263–281.
   Google Scholar
• Metzger R, Cole L. 2004. Solubility characterization of airborne uranium from a uranium recycling plant. Health Phys 87:89–91.
   PubMed Web of Science ®Google Scholar
• Metzger R, Wichers D, Vaselin J, Velasquez P. 1997. Solubility characterization of airborne uranium from an in situ uranium processing plant. Health Phys 72:418–422.
   PubMed Web of Science ®Google Scholar
• Morrow PE, Gibb FR, Johnson L. 1964. Clearance of insoluble dust from the lower respiratory tract. Health Phys 11:543–555.
   Google Scholar
• Morrow PE, Gibb FR, Beiter HD. 1972. Inhalation studies of uranium trioxide. Health Phys 23:273–280.
   PubMed Web of Science ®Google Scholar
• Morrow P, Gelein R, Beiter H, Scott J, Picano J, Yuile C. 1982. Inhalation and intravenous studies of UF6/UO2F2 in dogs. Health Phys 43: 859–873.
   PubMed Web of Science ®Google Scholar
• Pellow PG, Stradling GN, Hodgson A, Fell T, Phipps A, Ellender M. 1997. Absorption kinetics of uranium tri-n-butyl phosphate in the rat: Implications for occupational exposure. J Radioanalyt Nuclear Chem 226:93–98.
   Google Scholar
• *Pellow PG, Hodgson SA, Hodgson A, Rance E, Ellender M, Guilmette RA, Stradling GN. 2003. Comparison of absorption after inhalation and instillation of uranium octoxide. Radiat Protect Dosim 105:105–108.
   PubMedGoogle Scholar
• *Poncy JL, Métivier H, Dhilly M, Verry M, Masse R. 1992. In vitro dissolution of uranium oxide by baboon alveolar macrophages. Environ Health Perspect 97:127–130.
   PubMedGoogle Scholar
• Stradling GN, Stather JW, Strong JC, Sumner SA, Towndrow CG, Moody JC, Lennox A, Sedgwick D, Cooke N. 1985a. Metabolism of some industrial uranium tetrafluorides after deposition in the rat lung. Human Toxicol 4:159–168.
   PubMedGoogle Scholar
• Stradling GN, Stather JW, Ellender M, Sumner SA, Moody JC, Towndrow CG, Hodgson A, Sedgwick D, Cooke N. 1985b. Metabolism of an industrial uranium trioxide dust after deposition in the rat lung. Human Toxicol 4:563–572.
   PubMedGoogle Scholar
• Stradling GN, Stather JW, Gray SA, Moody JC, Ellender M, Hodgson A, Sedgwick D, Cooke N. 1987. Metabolism of uranium in the rat after inhalation of two industrial forms of ore concentrate: The implications for occupational exposure. Human Toxicol 6: 385–393.
   PubMedGoogle Scholar
• Stradling GN, Stather JW, Gray SA, Moody JC, Hodgson A, Sedgwick D, Cooke N. 1988. The metabolism of ceramic and non-ceramic forms of uranium dioxide after deposition in the rat lung. Human Toxicol 7:133–139.
   PubMedGoogle Scholar
• Stradling GN, Stather JW, Gray SA, Moody JC, Hodgson A. 1989. The metabolic behaviour of uranium octoxide bearing residues after their deposition in the rat lung: The implications for occupational exposure. Exp Pathol 37:76–82.
   PubMedGoogle Scholar
• Stradling GN, Gray SA, Moody JC, Ellender M, Pearce M. 1991. The biokinetic of thorium in the presence of a highly transportable form of uranium: The implications for occupational exposure. Report NRPB–M280.
   Google Scholar
• Stradling N, Hodgson A, Ansoborlo E, Bérard E, Etherington G, Fell T, Rance E, Le Guen B. 2002. Industrial uranium compounds: Exposure limits, assessment of intake and toxicity after inhalation. Report NRPB–W22.
   Google Scholar
• Stradling GN, Moody JC, Gray SA, Hodgson A, Collier CG, Ellender M. 2003. Metabolic behaviour of enriched uranium octoxide after deposition in the rat lung: Implications for occupational exposure. Report NRPB-DA/8/2003.
   Google Scholar
• *Sullivan MF. 1980a. Absorption of actinide elements from the gastrointestinal tract of rats, guinea pigs and dogs. Health Phys 38:159–171.
   PubMed Web of Science ®Google Scholar
• *Sullivan MF. 1980b. Absorption of actinide elements from gastrointestinal tract of neonatal animals. Health Phys 38:173–185.
   PubMed Web of Science ®Google Scholar
• *Sullivan MF, Ruemmler PS, Ryan JL, Buschbom RL. 1986. Influence of oxidizing or reducing agents on gastrointestinal absorption of U, Pu, Am, Cm and Pm by rats. Health Phys 50:223–232.
   PubMed Web of Science ®Google Scholar
• Thein M, Maitz AH, Austin MA, Rao GR, Gur D. 1982. Dissolution rates of airbone uranium in simulated lung fluid. Health Phys 43: 587–590.
   PubMedGoogle Scholar
• *Tracy BL, Quinn JM, Lahey J, Gilman AP, Mancuso K, Yagminast AP, Villeneuve DC. 1992. Absorption and retention of uranium from drinking water by rats and rabbits. Health Phys 62:65–73.
   PubMed Web of Science ®Google Scholar
• *Wrenn ME, Durbin PW, Howard B, Lipsztein J, Rundo J, Still ET, Willis DL. 1985. Metabolism of ingested U and Ra. Health Phys 48:601–633.
   PubMed Web of Science ®Google Scholar
• *Wrenn ME, Singh NP, Ruth H, Rallison ML, Burleigh DP. 1989. Gastrointestinal absorption of soluble uranium from drinking water by man. Radiat Protect Dosim 26:119–122.
   Google Scholar
• *Zamora ML, Zielinski JM, Meyerhof DP, Tracy BL. 2002. Gastrointestinal absorption of uranium in humans. Health Phys 83:35–45.
   PubMedGoogle Scholar